Doxorubicin sensitizes human tumor cells to NK cell- and T-cell-mediated killing by augmented TRAIL receptor signaling

Erik Wennerberg, Dhifaf Akef Sarhan, Mattias Carlsten, Vitaliy O. Kaminskyy, Padraig D'Arcy, Boris Zhivotovsky, Richard Childs, Andreas Lundqvist

Research output: Contribution to journalArticlepeer-review

41 Scopus citations

Fingerprint

Dive into the research topics of 'Doxorubicin sensitizes human tumor cells to NK cell- and T-cell-mediated killing by augmented TRAIL receptor signaling'. Together they form a unique fingerprint.

Medicine & Life Sciences